* Avanos Medical Inc AVNS.N reported quarterly adjusted
earnings
of 27 cents per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for earnings of
27 cents per share.
* Revenue fell 2.9% to $191.70 million from a year ago;
analysts
expected $195.20 million.
* Avanos Medical Inc's reported EPS for the quarter was a
loss of
1 cent.
* The mean earnings estimate of analysts had fallen by
about 20.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Avanos Medical Inc shares had fallen by 2.6% this
quarter and
gained 7.0% so far this year.
* The company reported a quarterly loss of $500 thousand.
* Wall Street's median 12-month price target for Avanos
Medical
Inc is $28.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
3 at 01:32 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 0.27 0.27 Met
Dec. 31 2022 0.49 0.60 Beat
Sep. 30 2022 0.35 0.38 Beat
Jun. 30 2022 0.38 0.41 Beat